在线监测工业烟气可凝结颗粒物的原型机

Search documents
打通“最初一公里”和“最后一公里” 上海支撑科技成果转化孵化 多维度助推专利从书柜走到货柜
Jie Fang Ri Bao· 2025-05-03 03:35
Group 1 - The transformation of scientific and technological achievements is a crucial part of the innovation chain, with Shanghai actively supporting this process through various initiatives [1] - The "first kilometer" and "last kilometer" are key indicators to assess the friendliness of the industrialization environment [1] Group 2 - The "first kilometer" involves not just the courage of scientists but also structured support, such as the "transformation clinic" at East China Normal University, which has engaged 122 participants across 110 projects [2] - A total of 20 projects have been selected for close follow-up and concept validation, demonstrating the effectiveness of the support system [2] Group 3 - Concept validation is identified as a critical step in the transformation process, with 22 projects currently in the concept validation center, leading to the development of 6 product prototypes [3] - Shanghai Jiao Tong University has initiated a concept validation center alliance, planning to establish over 10 validation sub-centers and allocate more than 100 million yuan for project support [3] Group 4 - Shanghai is enhancing its incubation capabilities by focusing on high-quality incubators and planning to establish around 20 by the end of the year, with an average of 180 new incubated companies monthly [4] Group 5 - The "last kilometer" challenges, such as engineering and financing issues, are being addressed through reforms that empower researchers, allowing them to retain ownership of their innovations [5] - East China Normal University has implemented a model where researchers retain all ownership rights, leading to a surge in entrepreneurial activity with nearly 40 new companies established in 2024 [6] Group 6 - Shanghai has pioneered several reforms to stimulate research enthusiasm and alleviate investor concerns, including a model that has facilitated the transformation of 22 projects with a total value exceeding 1 billion yuan [7] - The establishment of a 10 billion yuan biomedical acquisition fund aims to enhance innovation capabilities among leading enterprises in the sector [7]